Evidence map›Paper›PMID 38729950›Full record

ArticleNature communications2024

Multiplexed bulk and single-cell RNA-seq hybrid enables cost-efficient disease modeling with chimeric organoids.

Chen Cheng, Gang Wang, Yuqing Zhu, Hangdi Wu, Li Zhang, Zhihong Liu, Yuanhua Huang, Jin Zhang

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Chen Cheng *Center for Translational Stem Cell Biology, Hong Kong Science and Technology Park, Hong Kong SAR, China.
Gang Wang *Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0002-9804-2609
Yuqing ZhuCenter for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Bone Marrow for Transplantation Center of the First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Hangdi WuNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Li ZhangCenter for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Bone Marrow for Transplantation Center of the First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Zhihong LiuLiangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. liuzhihong@zju.edu.cn.ORCID http://orcid.org/0000-0001-6093-0726
Yuanhua HuangCenter for Translational Stem Cell Biology, Hong Kong Science and Technology Park, Hong Kong SAR, China. yuanhua@hku.hk.ORCID http://orcid.org/0000-0003-3124-9186
Jin ZhangLiangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. zhgene@zju.edu.cn.ORCID http://orcid.org/0000-0001-6691-1139

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31871453
6 · The paper itself

Abstract

Disease modeling with isogenic Induced Pluripotent Stem Cell (iPSC)-differentiated organoids serves as a powerful technique for studying disease mechanisms. Multiplexed coculture is crucial to mitigate batch effects when studying the genetic effects of disease-causing variants in differentiated iPSCs or organoids, and demultiplexing at the single-cell level can be conveniently achieved by assessing natural genetic barcodes. Here, to enable cost-efficient time-series experimental designs via multiplexed bulk and single-cell RNA-seq of hybrids, we introduce a computational method in our Vireo Suite, Vireo-bulk, to effectively deconvolve pooled bulk RNA-seq data by genotype reference, and thereby quantify donor abundance over the course of differentiation and identify differentially expressed genes among donors. Furthermore, with multiplexed scRNA-seq and bulk RNA-seq, we demonstrate the usefulness and necessity of a pooled design to reveal donor iPSC line heterogeneity during macrophage cell differentiation and to model rare WT1 mutation-driven kidney disease with chimeric organoids. Our work provides an experimental and analytic pipeline for dissecting disease mechanisms with chimeric organoids.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsOrganoidsRNA-SeqSingle-Cell AnalysisAnimalsHumansMacrophagesSequence Analysis, RNASingle-Cell Gene Expression Analysis

Identifiers

PMID38729950
PMCPMC11087505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.